One of the biggest concerns for patients undergoing skin grafting is scarring post-surgery and the regeneration of transplanted skin. The depth of scarring after suturing varies depending on… read more.
With skin cancer rates rising, much of it preventable, a new research project is to explore the role of primary schools in Wales and assess the effectiveness of… read more.
The Best Emollients for Eczema trial has found that no one type of moisturiser is better than another. This study, the first in the world to directly compare… read more.
As the most serious type of skin cancer, a melanoma diagnosis carries emotional, financial and medical consequences. That’s why recent studies finding that there is an overdiagnosis of… read more.
Human skin has evolved to allow maximum durability and flexibility, according to new research from Binghamton University, State University of New York. Associate Professor of Biomedical Engineering Guy… read more.
Kläre Bryant is an experienced clinical pharmacist who has specialised in dermatology. For the past nine years she run outpatient clinics at Liverpool University Hospitals for dermatology patients… read more.
There is now an interest group for specialist dermatology pharmacists and work is in progress with British Association of Dermatologists to develop suitable training. As Kläre Bryant, advanced… read more.
Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool University Hospitals, was a recently-qualified independent prescriber when she managed the switch to biosimilar infliximab for the cohort of… read more.
Feedback from a satisfied patient illustrates the impact that good pharmaceutical care can have on dermatological disease, according to Kläre Bryant, advanced clinical pharmacist in dermatology at Liverpool… read more.
Kläre Bryant is an advanced clinical pharmacist who has been holding clinics for dermatology patients receiving biologics and other systemic treatments for more than nine years. IMI spoke… read more.
A key ingredient is missing from all sunscreens and anti-aging creams, and our skin will be far better protected from the damaging effects of the sun once this… read more.
LEO Pharma announced up to 3.5-year data that further support the long-term safety and efficacy profile of Adbry (tralokinumab-ldrm) in adult patients with moderate-to-severe atopic dermatitis (AD). The… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
